Laraway Financial Advisors’s AbbVie ABBV Stock Holding History

Laraway Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375K	Buy	1,491 +23	+2%	+$4.95K	0.23%	102
2026 Q1	$319K	Sell	1,468 -299	-17%	-$66.3K	0.22%	103
2025 Q4	$404K	Sell	1,767 -5	-0.3%	-$1.14K	0.26%	85
2025 Q3	$410K	Hold	1,772	–	–	0.28%	83
2025 Q2	$329K	Sell	1,772 -24	-1%	-$4.46K	0.25%	93
2025 Q1	$376K	Buy	1,796 +1	+0.1%	+$194	0.3%	80
2024 Q4	$319K	Hold	1,795	–	–	0.25%	91
2024 Q3	$355K	Hold	1,795	–	–	0.28%	84
2024 Q2	$308K	Buy	1,795 +1	+0.1%	+$166	0.26%	85
2024 Q1	$327K	Hold	1,794	–	–	0.29%	86
2023 Q4	$278K	Buy	1,794 +1	+0.1%	+$146	0.26%	91
2023 Q3	$267K	Sell	1,793 -25	-1%	-$3.67K	0.28%	85
2023 Q2	$245K	Buy	1,818 +1	+0.1%	+$147	0.24%	93
2023 Q1	$290K	Hold	1,817	–	–	0.29%	89
2022 Q4	$294K	Sell	1,817 -33	-2%	-$5.06K	0.31%	89
2022 Q3	$248K	Hold	1,850	–	–	0.28%	94
2022 Q2	$283K	Sell	1,850 -50	-3%	-$7.64K	0.3%	87
2022 Q1	$307K	Buy	1,900 +50	+3%	+$7.26K	0.28%	91
2021 Q4	$250K	Buy	+1,850	New	+$219K	0.22%	98

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Laraway Financial Advisors's ABBV Position: Q2 2026 in Review

Laraway Financial Advisors increased its AbbVie (ABBV) stake by 1.6% in Q2 2026, buying an estimated $4.95K and bringing the position to 1,491 shares worth $375K. The position accounts for 0.23% of the portfolio, ranked #102.

Laraway Financial Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $410K in Q3 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Laraway Financial Advisors held 1,491 shares of AbbVie worth $375K as of Q2 2026.
Laraway Financial Advisors bought 23 AbbVie shares in Q2 2026, an estimated $4.95K.
AbbVie made up 0.23% of Laraway Financial Advisors's portfolio in Q2 2026, its #102 holding.
Laraway Financial Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
Laraway Financial Advisors's AbbVie position peaked at $410K in Q3 2025.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Laraway Financial Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.